Aranding, Rudy .
HRN: 05-75-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/11/2022
CEFUROXIME 750MG (VIAL)
10/11/2022
10/18/2022
IV
1.5g
7 Days
Post Hernia Repair
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes